Vault-13

Frazier Life Sciences Management, L.P.

PALO ALTO, CA · CIK 1892134 · 13F filing filed 2023-08-14

SEC-registered investment adviser since 2021 · limited partnership

As an employer

Where they work

people there (dot area)number not reportedmain officeHover or tap a dot. Australian and UK companies are placed at their business or registered address, with their staff across the whole country.

Offices

From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.

CityCountryPeople
Palo Alto, CA (main office)United States United Statesabout 44
San Diego, CAUnited States United States3

Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.

$1.7bn reported value +21.2% vs Q1 2023
48positions
66.8%in top 10
4 new 12 added 8 reduced 5 sold out vs Q1 2023

Holdings, Q2 2023

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 HILLEVAX INC COM COM 9,781,472 $168.1m10.04% 10.04% UnchangedShares held: Q3 2022 9.8m, Q4 2022 9.8m, Q1 2023 9.8m, Q2 2023 9.8m
2 CHINOOK THERAPEUTICS INC COM ADRO ADRO 4,345,559 $167.0m9.97% 9.97% UnchangedShares held: Q3 2022 4.3m, Q4 2022 4.3m, Q1 2023 4.3m, Q2 2023 4.3m
3 PHATHOM PHARMACEUTICALS INC COM PHAT PHAT 10,109,279 $144.8m8.65% 8.65% AddedShares held: Q3 2022 8.4m, Q4 2022 8.4m, Q1 2023 8.4m, Q2 2023 10.1m +1.7m +1,702,127 20.2%
4 NEWAMSTERDAM PHARMA COMPANY ORDINARY SHARES NAMS NAMS 10,871,803 $129.3m7.72% 7.72% AddedShares held: Q3 2022 0, Q4 2022 9.3m, Q1 2023 9.3m, Q2 2023 10.9m +1.5m +1,530,252 16.4%
5 KRYSTAL BIOTECH INC COM KRYS KRYS 990,260 $116.3m6.94% 6.94% AddedShares held: Q3 2022 1.0m, Q4 2022 999.7k, Q1 2023 945.4k, Q2 2023 990.3k +44.9k +44,853 4.7%
6 MIRUM PHARMACEUTICALS INC COM MIRM MIRM 4,360,107 $112.8m6.74% 6.74% AddedShares held: Q3 2022 3.8m, Q4 2022 3.9m, Q1 2023 3.9m, Q2 2023 4.4m +500.0k +500,000 12.9%
7 ARCUTIS BIOTHERAPEUTICS INC COM ARQT ARQT 8,684,232 $82.8m4.94% 4.94% UnchangedShares held: Q3 2022 8.7m, Q4 2022 8.7m, Q1 2023 8.7m, Q2 2023 8.7m
8 SYNDAX PHARMACEUTICALS INC COM SNDX SNDX 3,708,838 $77.6m4.64% 4.64% UnchangedShares held: Q3 2022 3.4m, Q4 2022 3.7m, Q1 2023 3.7m, Q2 2023 3.7m
9 VERONA PHARMA PLC SPONSORED ADS VRNA VRNA 2,944,349 $62.2m3.72% 3.72% UnchangedShares held: Q3 2022 2.1m, Q4 2022 2.8m, Q1 2023 2.9m, Q2 2023 2.9m
10 VAXCYTE INC COM PCVX PCVX 1,164,405 $58.2m3.47% 3.47% ReducedShares held: Q3 2022 1.5m, Q4 2022 1.4m, Q1 2023 1.4m, Q2 2023 1.2m -233.0k -233,000 -16.7%
11 RHYTHM PHARMACEUTICALS INC COM RYTM RYTM 2,167,222 $35.7m2.13% 2.13% AddedShares held: Q3 2022 1.9m, Q4 2022 1.9m, Q1 2023 2.2m, Q2 2023 2.2m +2.5k +2,483 0.1%
12 BRIDGEBIO PHARMA INC COM BBIO BBIO 1,988,876 $34.2m2.04% 2.04% AddedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 1.2m, Q2 2023 2.0m +817.2k +817,226 69.8%
13 TARSUS PHARMACEUTICALS INC COM TARS TARS 1,787,527 $32.3m1.93% 1.93% UnchangedShares held: Q3 2022 1.8m, Q4 2022 1.8m, Q1 2023 1.8m, Q2 2023 1.8m
14 ALPINE IMMUNE SCIENCES INC COM NVLS NVLS 2,985,757 $30.7m1.83% 1.83% UnchangedShares held: Q3 2022 3.0m, Q4 2022 3.0m, Q1 2023 3.0m, Q2 2023 3.0m
15 KALVISTA PHARMACEUTICALS INC COM KALV KALV 3,238,859 $29.1m1.74% 1.74% UnchangedShares held: Q3 2022 1.6m, Q4 2022 3.2m, Q1 2023 3.2m, Q2 2023 3.2m
16 DISC MEDICINE INC COM IRON IRON 655,000 $29.1m1.74% 1.74% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 655.0k
17 CRINETICS PHARMACEUTICALS IN COM CRNX CRNX 1,414,823 $25.5m1.52% 1.52% UnchangedShares held: Q3 2022 1.4m, Q4 2022 1.4m, Q1 2023 1.4m, Q2 2023 1.4m
18 REVOLUTION MEDICINES INC COM RVMD RVMD 854,484 $22.9m1.37% 1.37% UnchangedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 854.5k, Q2 2023 854.5k
19 THESEUS PHARMACEUTICALS INC COM COM 2,248,194 $21.0m1.25% 1.25% UnchangedShares held: Q3 2022 0, Q4 2022 1.4m, Q1 2023 2.2m, Q2 2023 2.2m
20 ACADIA PHARMACEUTICALS INC COM ACAD ACAD 857,338 $20.5m1.23% 1.23% UnchangedShares held: Q3 2022 857.3k, Q4 2022 857.3k, Q1 2023 857.3k, Q2 2023 857.3k
21 MERUS N V COM MRUS MRUS 746,479 $19.7m1.17% 1.17% UnchangedShares held: Q3 2022 746.5k, Q4 2022 746.5k, Q1 2023 746.5k, Q2 2023 746.5k
22 ANAPTYSBIO INC COM ANAB ANAB 899,700 $18.3m1.09% 1.09% UnchangedShares held: Q3 2022 899.7k, Q4 2022 899.7k, Q1 2023 899.7k, Q2 2023 899.7k
23 COGENT BIOSCIENCES INC COM COGT COGT 1,501,383 $17.8m1.06% 1.06% ReducedShares held: Q3 2022 2.1m, Q4 2022 2.1m, Q1 2023 2.2m, Q2 2023 1.5m -657.8k -657,771 -30.5%
24 TYRA BIOSCIENCES INC COM TYRA TYRA 1,028,013 $17.5m1.05% 1.05% ReducedShares held: Q3 2022 1.3m, Q4 2022 1.3m, Q1 2023 1.4m, Q2 2023 1.0m -393.3k -393,297 -27.7%
25 AEROVATE THERAPEUTICS INC COM COM 994,858 $17.1m1.02% 1.02% AddedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 338.1k, Q2 2023 994.9k +656.7k +656,748 194.2%
26 ENLIVEN THERAPEUTICS INC COM ELVN ELVN 830,983 $17.0m1.01% 1.01% UnchangedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 831.0k, Q2 2023 831.0k
27 ORIC PHARMACEUTICALS INC COM ORIC ORIC 2,142,855 $16.6m0.99% 0.99% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 2.1m
28 TREVI THERAPEUTICS INC COM TRVI TRVI 6,881,090 $16.4m0.98% 0.98% AddedShares held: Q3 2022 5.4m, Q4 2022 6.7m, Q1 2023 6.7m, Q2 2023 6.9m +217.5k +217,500 3.3%
29 MORPHIC HLDG INC COM MORF MORF 265,511 $15.2m0.91% 0.91% AddedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 214.2k, Q2 2023 265.5k +51.3k +51,271 23.9%
30 CEREVEL THERAPEUTICS HLDNG I COM CERE CERE 393,000 $12.5m0.75% 0.75% UnchangedShares held: Q3 2022 393.0k, Q4 2022 393.0k, Q1 2023 393.0k, Q2 2023 393.0k
31 REATA PHARMACEUTICALS INC CL A RETA RETA 100,430 $10.2m0.61% 0.61% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 100.4k
32 MACROGENICS INC COM MGNX MGNX 1,803,204 $9.6m0.58% 0.58% AddedShares held: Q3 2022 701.6k, Q4 2022 0, Q1 2023 1.7m, Q2 2023 1.8m +100.0k +100,000 5.9%
33 REPLIMUNE GROUP INC COM REPL REPL 386,762 $9.0m0.54% 0.54% ReducedShares held: Q3 2022 806.3k, Q4 2022 931.6k, Q1 2023 686.8k, Q2 2023 386.8k -300.0k -300,000 -43.7%
34 AUTOLUS THERAPEUTICS PLC SPON ADS AUTL AUTL 3,746,857 $8.9m0.53% 0.53% UnchangedShares held: Q3 2022 3.7m, Q4 2022 3.7m, Q1 2023 3.7m, Q2 2023 3.7m
35 PROTHENA CORP PLC SHS PRTA PRTA 127,900 $8.7m0.52% 0.52% UnchangedShares held: Q3 2022 0, Q4 2022 127.9k, Q1 2023 127.9k, Q2 2023 127.9k
36 INTELLIA THERAPEUTICS INC COM NTLA NTLA 203,684 $8.3m0.50% 0.50% UnchangedShares held: Q3 2022 203.7k, Q4 2022 203.7k, Q1 2023 203.7k, Q2 2023 203.7k
37 ARVINAS INC COM ARVN ARVN 285,331 $7.1m0.42% 0.42% UnchangedShares held: Q3 2022 285.3k, Q4 2022 285.3k, Q1 2023 285.3k, Q2 2023 285.3k
38 EDGEWISE THERAPEUTICS INC COM EWTX EWTX 749,022 $5.8m0.35% 0.35% AddedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 682.5k, Q2 2023 749.0k +66.6k +66,561 9.8%
39 IMMUNOVANT INC COM IMVT IMVT 300,000 $5.7m0.34% 0.34% ReducedShares held: Q3 2022 585.8k, Q4 2022 585.8k, Q1 2023 585.8k, Q2 2023 300.0k -285.8k -285,759 -48.8%
40 BLUEBIRD BIO INC COM COM 1,709,907 $5.6m0.34% 0.34% AddedShares held: Q3 2022 1.4m, Q4 2022 1.4m, Q1 2023 1.4m, Q2 2023 1.7m +269.1k +269,150 18.7%
41 DECIPHERA PHARMACEUTICALS IN COM DCPH DCPH 370,000 $5.2m0.31% 0.31% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 370.0k
42 SILENCE THERAPEUTICS PLC ADS SLN SLN 881,173 $4.8m0.29% 0.29% UnchangedShares held: Q3 2022 881.2k, Q4 2022 881.2k, Q1 2023 881.2k, Q2 2023 881.2k
43 GRITSTONE BIO INC COM GRTS GRTS 2,401,714 $4.7m0.28% 0.28% ReducedShares held: Q3 2022 5.2m, Q4 2022 5.2m, Q1 2023 5.2m, Q2 2023 2.4m -2.8m -2,760,634 -53.5%
44 SUTRO BIOPHARMA INC COM COM 780,000 $3.6m0.22% 0.22% ReducedShares held: Q3 2022 1.8m, Q4 2022 1.8m, Q1 2023 1.8m, Q2 2023 780.0k -996.5k -996,479 -56.1%
45 ADC THERAPEUTICS SA SHS ADCT ADCT 1,647,030 $3.5m0.21% 0.21% UnchangedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 1.6m, Q2 2023 1.6m
46 ACLARIS THERAPEUTICS INC COM ACRS ACRS 264,377 $2.7m0.16% 0.16% UnchangedShares held: Q3 2022 408.3k, Q4 2022 290.2k, Q1 2023 264.4k, Q2 2023 264.4k
47 PASSAGE BIO INC COM COM 1,850,000 $1.7m0.10% 0.10% ReducedShares held: Q3 2022 3.8m, Q4 2022 3.8m, Q1 2023 3.8m, Q2 2023 1.9m -1.9m -1,906,915 -50.8%
48 NEWAMSTERDAM PHARMA COMPANY *W EXP 11/22/202 NAMSW NAMSW 500,333 $1.0m0.06% 0.06% UnchangedShares held: Q3 2022 0, Q4 2022 500.3k, Q1 2023 500.3k, Q2 2023 500.3k

Sold out since Q1 2023

SecurityTickerShares held beforeValue then
VECTIVBIO HLDG AG 1,352,199 $11.6m1.4m shares
AVIDITY BIOSCIENCES INC RNA RNA 500,000 $7.7m500.0k shares
ZYMEWORKS INC ZYME ZYME 610,000 $5.5m610.0k shares
ALLAKOS INC ALLKG ALLKG 1,112,684 $5.0m1.1m shares
NABRIVA THERAPEUTICS PLC NBRVF NBRVF 17,025 $29.7k17.0k shares